Skip to content
10-Q

Quarterly Report

PROTO SCRIPT PHARMACEUTICAL CORP

0001640334-17-002503

← back to feed
Filed
Nov 22, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Nov 21, 2017 49.14M sh
Capex Q1 2017 · Mar 31, 2017 $9.38K
Cash And Equivalents Q1 2017 · Mar 31, 2017 $56.36K
Cash And Equivalents Q1 2017 · Dec 31, 2016 $3.51K
Cash And Equivalents Q1 2017 · Mar 31, 2016 $21.78K
Cash And Equivalents Q1 2017 · Dec 31, 2015 $9.09K
Stockholders Equity Q1 2017 · Mar 31, 2017 −$825.6K
Stockholders Equity Q1 2017 · Dec 31, 2016 −$319.74K
Current Liabilities Q1 2017 · Mar 31, 2017 $1.05M
Current Liabilities Q1 2017 · Dec 31, 2016 $489.93K
Current Assets Q1 2017 · Mar 31, 2017 $196.17K
Current Assets Q1 2017 · Dec 31, 2016 $144.65K
Total Assets Q1 2017 · Mar 31, 2017 $229.09K
Total Assets Q1 2017 · Dec 31, 2016 $170.19K
Sga Expense Q1 2017 · Mar 31, 2017 $369.08K
Sga Expense Q1 2017 · Mar 31, 2016 $165.4K
Net Income Q1 2017 · Mar 31, 2017 −$505.87K
Net Income Q1 2017 · Dec 31, 2016 −$7.18M
Net Income Q1 2017 · Mar 31, 2016 $149.09K
Operating Income Q1 2017 · Mar 31, 2017 −$261.73K
Operating Income Q1 2017 · Mar 31, 2016 $149.09K
Gross Profit Q1 2017 · Mar 31, 2017 $107.34K
Gross Profit Q1 2017 · Mar 31, 2016 $314.49K
Cost Of Revenue Q1 2017 · Mar 31, 2017 $30.94K
Cost Of Revenue Q1 2017 · Mar 31, 2016 $28.72K
Dividends Paid Q1 2017 · Mar 31, 2016 $34.54K